A Phase 2, Randomized, Double-Blind, Multi-center Study Comparing CLP Versus Placebo in Heart Failure Patients With Chronic Kidney Disease

Trial Profile

A Phase 2, Randomized, Double-Blind, Multi-center Study Comparing CLP Versus Placebo in Heart Failure Patients With Chronic Kidney Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2013

At a glance

  • Drugs Talinexomer (Primary)
  • Indications Heart failure; Kidney disorders
  • Focus Adverse reactions
  • Sponsors Sorbent Therapeutics
  • Most Recent Events

    • 10 Sep 2012 Data presented at the 16th Annual Meeting of the Heart Failure Society of America, according to a Sorbent Therapeutics media release
    • 23 May 2012 New source identified and integrated (ClinicalTrials.gov)
    • 22 May 2012 Data presented at the Annual European Society of Cardiology Heart Failure Congress, according to a Sorbent Therapeutics media release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top